CIK 0001806310
- Non-accelerated filer
- Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843199512
- Phone
- +1 214-612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Nolan Sean P. Chief Executive Officer | Sale | −41,312 | $4.61 | $190K | 2,908,257 |
| 2026-01-23 | Nolan Sean P. Chief Executive Officer | Sale | −136,789 | $4.75 | $650K | 2,949,569 |
| 2026-01-12 | Nolan Sean P. Chief Executive Officer | Grant or award | +1,008,000 | 3,086,358 | ||
| 2026-01-12 | Nolan Sean P. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +648,000 | 648,000 | ||
| 2025-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award | +892,500 | 2,078,358 | ||
| 2025-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +892,500 | 892,500 | ||
| 2024-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award | +1,184,688 | 1,185,858 | ||
| 2024-01-02 | Nolan Sean P. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +1,184,688 | 1,184,688 | ||
| 2023-12-14 | Nolan Sean P. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +466,550 | 466,550 | ||
| 2023-08-16 | Nolan Sean P. Chief Executive Officer | Purchase | +444,444 | $0.90 | $400K | 1,535,545 |
| 2022-12-30 | Nolan Sean P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,106,131 | 1,106,131 | ||
| 2022-06-17 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2021-06-17 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2021-05-20 | Nolan Sean P. Director | Purchase | +1,170 | $22.35 | $26K | 1,170 |
| 2020-09-28 | Nolan Sean P. Director | Conversion | +1,089,500 | 1,089,500 | ||
| 2020-09-28 | Nolan Sean P. Director | Conversion | +1,601 | 1,091,101 | ||
| 2020-09-28 | Nolan Sean P. Director | Conversion · Series A Preferred Stock | −1,000,000 | 0 | ||
| 2020-09-28 | Nolan Sean P. Director | Conversion · Series B Preferred Stock | −1,470 | 0 | ||
| 2020-09-23 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 |
Page 1 of 1 · 19 trades